KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Liabilities and Shareholders Equity: 2020-2024

Historic Liabilities and Shareholders Equity for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Dec 2024 value amounting to $1.4 billion.

  • Ginkgo Bioworks Holdings' Liabilities and Shareholders Equity fell 19.70% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 billion, marking a year-over-year decrease of 19.87%. This contributed to the annual value of $1.4 billion for FY2024, which is 17.29% down from last year.
  • Ginkgo Bioworks Holdings' Liabilities and Shareholders Equity amounted to $1.4 billion in FY2024, which was down 17.29% from $1.7 billion recorded in FY2023.
  • In the past 5 years, Ginkgo Bioworks Holdings' Liabilities and Shareholders Equity registered a high of $2.5 billion during FY2022, and its lowest value of $675.2 million during FY2020.
  • In the last 3 years, Ginkgo Bioworks Holdings' Liabilities and Shareholders Equity had a median value of $1.7 billion in 2023 and averaged $1.9 billion.
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' Liabilities and Shareholders Equity surged by 206.74% in 2021, and later plummeted by 34.42% in 2023.
  • Yearly analysis of 5 years shows Ginkgo Bioworks Holdings' Liabilities and Shareholders Equity stood at $675.2 million in 2020, then surged by 206.74% to $2.1 billion in 2021, then grew by 22.61% to $2.5 billion in 2022, then plummeted by 34.42% to $1.7 billion in 2023, then dropped by 17.29% to $1.4 billion in 2024.